Silicon-based antibody optimization
A computational method for designing and screening antibody sequences in silico, using predictive models as oracles to provide quantitative scores such as binding affinity while an optimization algorithm searches sequence space for high-scoring variants.
Timeline (last 90 days)
The researchers evaluated MEMIG on in-silico antibody optimization tasks, and the results show that MEMIG improves performance in most settings.
In-silico antibody optimization refers to designing and screening antibody sequences in a computer-simulated environment rather than synthesizing and testing them one by one in wet-lab experiments; a typical pipeline includes defining the mutation space, using a predictive model as the oracle for scoring, and having an optimization algorithm search for high-scoring variants.
All Facts (2)
The researchers evaluated MEMIG on in-silico antibody optimization tasks, and the results show that MEMIG improves performance in most settings.
50%UnverifiedIn-silico antibody optimization refers to designing and screening antibody sequences in a computer-simulated environment rather than synthesizing and testing them one by one in wet-lab experiments; a typical pipeline includes defining the mutation space, using a predictive model as the oracle for scoring, and having an optimization algorithm search for high-scoring variants.
50%